Asia-Pacific Over The Counter (OTC) Drugs Market - - Growth, Trends & Forecast (2017 - 2022)

The Asia-Pacific Over-the-Counter (OTC) drugs market has been estimated at USD XX billion in 2016 and is projected to reach USD XX billion by 2021, growing at a CAGR of about X% during the forecast period from 2016 to 2021. Over-the-counter drugs are medications that can be secured without the need of a physicianprescription.

Asia-Pacific Over-the-Counter (OTC) Drugs Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are discussed below.


Some of the factors contributing to the growth of the market are:

Ease of accessibility

Lower costs compared to prescription drugs

Increased preference for using OTC drugs for minor health ailments

Increased spending on healthcare

Product innovations and technological advances


In spite of the high demand for OTC drugs in Asia-Pacific, there are some factors restraining the market. These include high competition among market players and the cost sensitivity of production.

The Asia-Pacific OTC drugs market has been segmented on the basis of the type of product and geography. By the type of product, the market is segmented into cough, cold and flu products, analgesics, dermatological products, gastrointestinal products, vitamins, minerals, weight loss/dietary products, ophthalmic products, sleep aids, smoking cessation aids and others.

By geography, the market is segmented into Australia & New Zealand, China, India, Japan and South Korea, with Australia, India, and China dominating the market. Japan is also an emerging market that has a scope for growth and can potentially dominate the market in the future.

Some of the key players in the market are:



Bayer Healthcare

Boehringer Ingelheim GmbH

Bristol- Myers Squibb

Cardinal Health


Johnson & Johnson

Key Deliverables in the Study

Market analysis for the Asia-Pacific OTC drugs market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the Asia-Pacific OTC drugs market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Characterization

5.1 Current Market Scenario

5.2 Market Overview

5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis

5.3.1 Market Drivers Increased Preference to use OTC drugs for Minor Health Ailments Increased Spending on Healthcare

5.3.2 Market Restraints Competition

5.3.3 Market Opportunities Product Innovations Technology Advances

5.3.4 Market Challenges Cost Sensitivity for Production

5.4 Over the Counter Drugs Market Segmentation

5.4.1 By Product Cough, Cold and Flu Products Analgesics Dermatological Products Gastrointestinal Products Vitamins Minerals Weight Loss/Dietary Products Ophthalmic Products Sleep Aids Smoking Cessation Aids Others

5.4.2 By Geography Asia-Pacific Australia & New Zealand China India Japan South Korea

6. Industry Analysis

6.1 Key Trends and Developments

6.2 Investment Analysis

6.3 PorterFive Forces

6.3.1 Bargaining Power of Suppliers

6.3.2 Bargaining Power of Consumers

6.3.3 Threat of New Entrants

6.3.4 Threat of Substitute Products and Services

6.3.5 Competitive Rivalry within the Industry

7. Competitive Landscape

7.1 Key Market Players

7.1.1 Abbott Abbott - Business Overview Abbott - Product and Services Portfolio Abbott - Deals Landscape Abbott - SWOT Analysis

7.1.2 AstraZeneca

7.1.3 Bayer Healthcare

7.1.4 Boehringer Ingelheim GmbH

7.1.5 Bristol- Myers Squibb

7.1.6 Cardinal Health

7.1.7 GlaxoSmithKline

7.1.8 Johnson & Johnson

7.1.9 Merck & Co

7.1.10 Novartis

7.1.11 Pfizer

7.1.12 Reckitt Benckiser

7.1.13 Sanofi Aventis

7.1.14 Others

7.2 Merger and Acquisition Analysis

7.3 New Product Launches

7.4 Agreements, Collaborations & Partnerships

8. Analyst Outlook for Investment Opportunities

9. Future Outlook of the Market

Content are not available

Choose License Type